Evaluation of the Quantum II yeast identification system Journal Article


Authors: Kiehn, T. E.; Edwards, F. F.; Tom, D.; Lieberman, G.; Bernard, E. M.; Armstrong, D.
Article Title: Evaluation of the Quantum II yeast identification system
Abstract: We compared three methods for identifying clinical yeast isolates: Abbott Quantum II, API 20C, and a modified BBL Minitek system. The API 20C and modified Minitek systems agreed on the identification of 243 of 245 yeasts (99.2%). The Quantum II system correctly identified 197 (80.4%), incorrectly identified 19 (7.8%), and did not identify 29 (11.8%) of the yeasts. Most of the misidentifications with the Quantum II occurred because assimilation or biochemical results were false-positive. Sixteen different species of yeasts and 16 different Quantum II substrates contributed to the discrepancies. On retesting with the Quantum II, 31% of the discrepant strains were correctly identified, while the remaining 69% were incorrectly identified or were not identified. Erroneous biochemical and assimilation results were also noted with yeasts that were correctly identified by the Quantum II system.
Keywords: unclassified drug; nonhuman; methodology; in vitro study; diagnosis; yeast; technique; fungus; fungi; fungus identification; priority journal; article; api 20c; automated antimicrobial sensitivity testing system
Journal Title: Journal of Clinical Microbiology
Volume: 22
Issue: 2
ISSN: 0095-1137
Publisher: American Society for Microbiology  
Date Published: 1985-08-01
Start Page: 216
End Page: 219
Language: English
DOI: 10.1128/jcm.22.2.216-219.1985
PROVIDER: scopus
PMCID: PMC268362
PUBMED: 3897264
DOI/URL:
Notes: Article -- Export Date: 26 October 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Timothy E Kiehn
    100 Kiehn
  2. Donald Armstrong
    240 Armstrong
  3. Edward M Bernard
    58 Bernard
  4. Fitzroy F Edwards
    23 Edwards